- Home
- FGEN vs NMTC Comparison
FGEN vs NMTC Comparison
Compare FGEN & NMTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FGEN
- NMTC
- Stock Information
- Founded
- FGEN 1993
- NMTC 2009
- Country
- FGEN United States
- NMTC United States
- Employees
- FGEN N/A
- NMTC N/A
- Industry
- FGEN Biotechnology: Pharmaceutical Preparations
- NMTC Medical/Dental Instruments
- Sector
- FGEN Health Care
- NMTC Health Care
- Exchange
- FGEN Nasdaq
- NMTC Nasdaq
- Market Cap
- FGEN 33.5M
- NMTC 33.8M
- IPO Year
- FGEN 2014
- NMTC N/A
- Fundamental
- Price
- FGEN $7.58
- NMTC $0.72
- Analyst Decision
- FGEN Strong Buy
- NMTC Strong Buy
- Analyst Count
- FGEN 1
- NMTC 1
- Target Price
- FGEN $250.00
- NMTC $1.45
- AVG Volume (30 Days)
- FGEN 65.9K
- NMTC 179.3K
- Earning Date
- FGEN 08-05-2025
- NMTC 08-13-2025
- Dividend Yield
- FGEN N/A
- NMTC N/A
- EPS Growth
- FGEN N/A
- NMTC N/A
- EPS
- FGEN N/A
- NMTC N/A
- Revenue
- FGEN $6,996,000.00
- NMTC $5,758,777.00
- Revenue This Year
- FGEN N/A
- NMTC $157.28
- Revenue Next Year
- FGEN N/A
- NMTC $41.79
- P/E Ratio
- FGEN N/A
- NMTC N/A
- Revenue Growth
- FGEN N/A
- NMTC 54.53
- 52 Week Low
- FGEN $4.50
- NMTC $0.40
- 52 Week High
- FGEN $38.25
- NMTC $1.39
- Technical
- Relative Strength Index (RSI)
- FGEN 59.10
- NMTC 57.22
- Support Level
- FGEN $7.03
- NMTC $0.69
- Resistance Level
- FGEN $5.73
- NMTC $0.77
- Average True Range (ATR)
- FGEN 0.52
- NMTC 0.04
- MACD
- FGEN 0.30
- NMTC -0.00
- Stochastic Oscillator
- FGEN 85.45
- NMTC 53.50
About FGEN FibroGen Inc
FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates. Geographically, it operates in United States, Japan, Europe and Others.
About NMTC NeuroOne Medical Technologies Corporation
NeuroOne Medical Technologies Corp operates as a medical technology company. It is focused on the development and commercialization of thin-film electrode technology for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording, brain stimulation, and ablation solutions for patients suffering from brain-related disorders. The company business is in one operating segment, which is the business of development and commercialization of products related to comprehensive neuromodulation cEEG and sEEG recording, monitoring, ablation, and brain stimulation solutions.